Palbociclib
Cat.No:IP5140 Solarbio
CAS:571190-30-2
Molecular Formula:C24H29N7O2
Molecular Weight:447.53
Storage:Powder:2-8℃,2 years;Insolvent(Mother Liquid):-20℃,6 months;-80℃,1 year
Purity:≥98%
Appearance:Solid
Qty:
Size:
{{cart_num}}
My Cart>
Small Molecule Compounds >
Inhibitors & Antagonists & Agonists >
Cell Cycle >
PalbociclibCAS:571190-30-2
Molecular Formula:C24H29N7O2
Molecular Weight:447.53
Storage:Powder:2-8℃,2 years;Insolvent(Mother Liquid):-20℃,6 months;-80℃,1 year
Purity:≥98%
Appearance:Solid
Qty:
Size:
CAS | 571190-30-2 |
Name | Palbociclib |
Molecular Formula | C24H29N7O2 |
Molecular Weight | 447.53 |
Solubility | Soluble in DMSO(Need ultrasonic) |
Purity | ≥98% |
Appearance | Solid |
Storage | Powder:2-8℃,2 years;Insolvent(Mother Liquid):-20℃,6 months;-80℃,1 year |
MDL | MFCD11840850 |
SMILES | CC1=C(C(=O)N(C2=NC(=NC=C12)NC3=NC=C(C=C3)N4CCNCC4)C5CCCC5)C(=O)C |
InChIKey | AHJRHEGDXFFMBM-UHFFFAOYSA-N |
InChI | InChI=1S/C24H29N7O2/c1-15-19-14-27-24(28-20-8-7-18(13-26-20)30-11-9-25-10-12-30)29-22(19)31(17-5-3-4-6-17)23(33)21(15)16(2)32/h7-8,13-14,17,25H,3-6,9-12H2,1-2H3,(H,26,27,28,29) |
PubChem CID | 5330286 |
Target Point | CDK |
Passage | Cell Cycle |
Background | It is an orally active selective inhibitor of CDK4 and CDK6, which has anti-proliferative activity on cancer cells and induces cell cycle arrest. It can be used in HR-positive and HER2-negative breast cancer, as well as related studies of hepatocellular carcinoma. |
Biological Activity | Palbociclib 是一种口服活性选择性 CDK4 和 CDK6 抑制剂,IC50 值分别为 11 和 16 nM。Palbociclib 具有很强的抗增殖活性,能诱导癌细胞的细胞周期停滞,可用于 HR 阳性和 HER2 阴性乳腺癌和肝细胞癌的研究。[1-3] |
IC50 | Cdk4/cyclin D3: 9nM(IC50);Cdk4/cyclin D1: 11nM(IC50);Cdk6/cyclin D2: 16nM(IC50) [1] |
Data Literature Source | [1]. Fry DW,et al. Specific inhibition of cyclin-dependent kinase 4/6 by PD 0332991 and associated antitumor activity in human tumor xenografts. Mol Cancer Ther. 2004 Nov;3(11):1427-38. [2]. Finn RS,et al. PD 0332991,a selective cyclin D kinase 4/6 inhibitor,preferentially inhibits proliferation of luminal estrogen receptor-positive human breast cancer cell lines in vitro. Breast Cancer Res. 2009;11(5):R77. [3]. Bollard J,et al. Palbociclib (PD-0332991),a selective CDK4/6 inhibitor,restricts tumour growth in preclinical models of hepatocellular carcinoma. Gut. 2017 Jul;66(7):1286-1296. |
Unit | Bottle |
Specification | 5mg |
Remark:These protocols are for reference only. Solarbio does not independently validate these methods.
Note:
1. The products are all for scientific research use only. Do not use it for medical, clinical diagnosis or treatment, food and cosmetics, etc. Do not store them in ordinary residential areas.
2. For your safety and health, please wear laboratory clothes, disposable gloves and masks.
3. The experimental results may be affected by many factors, after-sale service is limited to the product itself and does not involve other compensation.
Sorry, there is no more information.
Sorry, there is no more information.